Juha Rantala is currently the Translational Science Lead in Oncology at Orion Pharma and serves as the CEO and Principal Investigator at Misvik Biology Ltd. Previously, Rantala worked as a Lecturer at the University of Sheffield from 2019 to 2022, and as the Target Identification Lead in Oncology at Orion Corporation in 2022. From 2011 to 2014, they held the position of Research Assistant Professor at the Knight Cancer Institute, Oregon Health & Science University, and spent eight years as a Research Scientist at VTT. Rantala is pursuing a Doctor of Philosophy (Ph.D.) in Biochemistry at Turun yliopisto.
This person is not in the org chart
This person is not in any teams
This person is not in any offices